fda update tirzepatide says the weight-loss drug shortage is over FDA's tirzepatide decision creates uncertainty

Wegovy is a type of GLP-1 medication specifically approved for weight management

10.1016/j.copbio.2008.03.003 Curr Opin Biotechnol

PlexusDx recommends establishing a routine you can sustain long-term rather than trying to match a specific pre-injection eating pattern, since the medication's effectiveness does not depend on fasting or feeding status

It is important that people who are prescribed GLP-1 analogues continue to take them and contact their diabetes team if they have any concerns. References [1] US Food and Drug Adminstration

In people who have a body mass index of over 35, some of the best solutions that keep the weight off for a few years, studies show, are bariatric surgery (an operation that makes your stomach smaller and so helps you to eat less) or appetite-suppressing medicines such as Ozempic